Revenue sharply beat expectations; guidance rose, but dilution funded the expansion.

The quarter materially beat the market’s revenue expectation. Revenue reached $20.7 million, up 52.3% year over year, versus published Q2 expectations of roughly $13.5–$13.8 million—an unusually wide upside gap. The beat was driven mainly by 3D printer and parts sales, which rose to $19.0 million from $12.1 million, while support, license and recurring revenue increased only modestly to $1.7 million (Financial Summary).

The full-year outlook improved, but the raise is partly a catch-up to strong first-half execution. Management increased 2026 revenue guidance to $65 million–$75 million from $60 million–$70 million, explicitly citing first-half performance, backlog and pipeline (2026 Outlook). With first-half revenue already at $34.5 million, the new range implies approximately $30.5 million–$40.5 million in second-half revenue. That is a genuine positive revision, although the midpoint increase is only $5 million and the company still needs a substantial second-half ramp to reach the upper end.

Profitability remains the unresolved part of the story. Gross margin improved sharply to 21.5% from negative 11.7%, but it remains below the company’s target of greater than 30% in the second half of 2026 (Financial Summary; 2026 Outlook). Adjusted EBITDA was still negative $8.1 million, with adjusted operating expenses rising to $13.1 million from $8.8 million. The reaffirmed goal of positive EBITDA in the second half was already part of the prior outlook, so it adds less incremental information than the revenue beat or guidance increase.

The growth plan was funded with substantial equity issuance. Velo3D raised approximately $50 million gross through a registered direct offering and another $59.4 million gross through its at-the-market program during Q2 (Strengthened Balance Sheet Through Registered Direct Offering and At-the-Market Program). That materially improves near-term liquidity and supports planned capital expenditures of $40 million–$50 million, mainly for RPS expansion, but it also increases dilution and underscores that the expansion is not yet self-funded by operations.

Net read: clearly better demand, with execution and financing still tempering the upside. The revenue beat and higher guidance are the dominant new information and land materially above expectations. However, the quarter does not yet prove the promised margin conversion or positive EBITDA, while the tripling-capacity Livermore campus remains expected rather than operational (Expected to Triple Production Capacity to Support Accelerated Demand). The filing therefore improves the growth picture substantially, but leaves the profitability and dilution trade-offs firmly in view.